Molecular pathways to CML stem cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/content/pdf/10.1007/s12185-010-0615-8.pdf
Reference44 articles.
1. Deininger M, O’Brien SG, et al. International randomized study of interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib. Blood. 2009;114 (ASH Annual Meeting Abstract 1126).
2. Mahon F, Rea D, et al. Persistence of complete molecular remission in chronic myeloid leukemia after imatinib discontinuation: interim analysis of the STIM trial. J Clin Oncol 2009;27(15s) (Abstract 7084).
3. Graham SM, Jorgensen HG, et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99(1):319–25.
4. Minami Y, Stuart SA, et al. BCR-ABL-transformed GMP as myeloid leukemic stem cells. PNAS. 2008;105(46):17967–72.
5. Jamieson CHM. Chronic myeloid leukemia stem cells. Hematology. 2008. p. 436–42.
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PPFIA1-targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration;Molecular Therapy - Nucleic Acids;2023-06
2. Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies;Cells;2022-05-31
3. A Novel Fluorescent Dye Invades Mitochondria to Selectively Kill Cancer Stem Cells via Increased ROS Production;Bioinorganic Chemistry and Applications;2021-10-13
4. Bone marrow niche crosses paths with BMPs: a road to protection and persistence in CML;Biochemical Society Transactions;2019-09-24
5. CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia;Leukemia;2019-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3